I-Chow Hsu, MD

Title(s)Professor, Radiation Oncology
SchoolSchool of Medicine
Address1600 Divisadero, #H1027
San Francisco CA 94115
Phone415-476-5721
PronounsHe/Him/His
ORCID ORCID Icon0000-0002-3113-121X Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Johns HopkinsM.D.1991Medicine
    University of FloridaB.S.1987Biochemistry
    Collapse Awards and Honors
    UCSF2006ARRO Teacher of the Year
    UCSF2008Lawrence Margolis Lifetime Teaching Award
    UCSF2008ARRO Teacher of the Year
    UCSF2009ARRO Teacher of the Year
    ACR2010Fellow of American College of Radiology
    ASTRO2014Fellow of American Society for Radiation Oncology
    UCD2017Hideo Kubo Memorial Letcturer
    UCSF2017ARRO Teacher of the Year
    ABS2019Best Abstract Award

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Collaboration Interests

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Treatment Planning Strategies for Interstitial Ultrasound Ablation of Prostate Cancer. IEEE Open J Eng Med Biol. 2024; 5:362-375. Gupta P, Heffter T, Zubair M, Hsu IC, Burdette EC, Diederich CJ. PMID: 38899026; PMCID: PMC11186654.
      View in: PubMed   Mentions:
    2. Safety of high-dose-rate brachytherapy in patients with prostate cancer and inflammatory bowel disease: A case series. J Contemp Brachytherapy. 2024 Feb; 16(1):1-5. Thomas H, Chen JJ, Shaheen H, Sabbagh A, Abdul-Baki H, Chau OW, Malik N, Ayoub A, Hassanzadeh C, Hsu IC, Mohamad O. PMID: 38584887; PMCID: PMC10993899.
      View in: PubMed   Mentions:
    3. Safety of high-dose rate (HDR) brachytherapy for patients with prostate cancer and history of prior chemoradiation for rectal cancer: A case series. Brachytherapy. 2024 Mar-Apr; 23(2):173-178. Thomas H, Chen JJ, Abdul-Baki H, Sabbagh A, Shaheen H, Chau OW, Malik N, Ayoub A, Hassanzadeh C, Hsu IC, Mohamad O. PMID: 38160102.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Feasibility and Clinical Acceptability of Automation-Assisted 3D Conformal Radiotherapy Planning for Patients With Cervical Cancer in a Resource-Constrained Setting. JCO Glob Oncol. 2023 09; 9:e2300050. Muya S, Ndumbalo J, Kutika Nyagabona S, Yusuf S, Rhee DJ, Mushi BP, Li B, Zhang L, Grover S, Feng M, Hsu IC, Mmbaga E, Van Loon K, Court L, Xu M. PMID: 37725767; PMCID: PMC10581615.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study. Radiother Oncol. 2023 07; 184:109672. Corkum MT, Buyyounouski MK, Chang AJ, Chung HT, Chung P, Cox BW, Crook JM, Davis BJ, Frank SJ, Henriquez I, Horwitz EM, Hoskin P, Hsu IC, Keyes M, King MT, Kollmeier MA, Krauss DJ, Kukielka AM, Morton G, Orio PF, Pieters BR, Potters L, Rossi PJ, Showalter TN, Solanki AA, Song D, Vanneste B, Vigneault E, Wojcieszek PA, Zelefsky MJ, Kamrava M. PMID: 37059334.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    6. Outcomes of salvage high dose-rate brachytherapy with or without pelvic external beam radiotherapy in patients with palpable local recurrence of prostate cancer after radical prostatectomy. Brachytherapy. 2023 May-Jun; 22(3):304-309. Ni L, Chen K, Phuong C, Sabbagh AR, Wong AC, Mohamad O, Hsu IC. PMID: 36623988.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. The role of adjuvant radiation therapy in older patients with node-positive vulvar cancer: A national cancer database analysis. Gynecol Oncol. 2022 11; 167(2):189-195. Ni L, Sinha S, Rara M, Phuong C, Chen LM, Hsu IJ, Yoshida EJ. PMID: 36150913.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. Feasibility of accelerated image-guided high-dose-rate interstitial brachytherapy with inverse planning simulated annealing (IPSA-HDRBT) for post-operative treatment of pathologically node-negative squamous cell carcinomas of the oral tongue. Brachytherapy. 2022 Sep-Oct; 21(5):686-691. Cheung CK, Chew J, Wai K, Calkins SM, Ha PK, Ryan WR, Cunha A, Yom SS, Hsu IC, Chan JW. PMID: 35715306.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Relative Incidence of Emergency Department Visits After Treatment for Prostate Cancer With Radiation Therapy or Radical Prostatectomy. Pract Radiat Oncol. 2022 Sep-Oct; 12(5):e415-e422. Alexander J, Beatty A, Mohamad O, Hsu IJ. PMID: 35595216.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Ultrasound guidance for cervical implantation. Int J Gynecol Cancer. 2022 03; 32(3):266-272. Hsu IC, Yoshida E. PMID: 35256412.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Safety of accelerated hypofractionated whole pelvis radiation therapy prior to high dose rate brachytherapy or stereotactic body radiation therapy prostate boost. Radiat Oncol. 2022 Jan 20; 17(1):12. Phuong C, Chan JW, Ni L, Wall P, Mohamad O, Wong AC, Hsu IC, Chang AJ. PMID: 35057827; PMCID: PMC8772149.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. Comparison of novel shielded nasopharynx applicator designs for intracavitary brachytherapy. Brachytherapy. 2022 Mar-Apr; 21(2):229-237. Insley B, Goldberg K, Beaulieu L, Ma Y, McKinley S, Hsu IC, Cunha JA. PMID: 35067466.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Paradigm Shift in Radiation Treatment Planning Over Multiple Treatment Modalities. J Med Phys. 2021 Jul-Sep; 46(3):135-139. Insley B, Hsu IC, Cunha JAM. PMID: 34703096; PMCID: PMC8491309.
      View in: PubMed   Mentions:
    14. Unresectable bulky chest wall recurrent breast cancer controlled with CT-guided interstitial high-dose-rate brachytherapy and external beam radiotherapy with adjuvant hormonal therapy - case report. J Contemp Brachytherapy. 2021 Aug; 13(4):451-457. Kunogi H, Hsu IC, Sasai K. PMID: 34484361; PMCID: PMC8407259.
      View in: PubMed   Mentions:
    15. High-dose-rate interstitial brachytherapy for vaginal endometrial cancer recurrence after prior surgery and radiotherapy. Brachytherapy. 2021 May-Jun; 20(3):536-542. Chapman CH, Cunha AJ, Littell RD, Chen LM, Hsu IC. PMID: 33549517.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Stereotactic Body Radiation Therapy and High-Dose-Rate Brachytherapy Boost in Combination With Intensity Modulated Radiation Therapy for Localized Prostate Cancer: A Single-Institution Propensity Score Matched Analysis. Int J Radiat Oncol Biol Phys. 2021 06 01; 110(2):429-437. Chen WC, Li Y, Lazar A, Altun A, Descovich M, Nano T, Ziemer B, Sudhyadhom A, Cunha A, Thomas H, Gottschalk A, Hsu IC, Roach M. PMID: 33385496.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    17. Long-Term Results of NRG Oncology/RTOG 0321: A Phase II Trial of Combined High Dose Rate Brachytherapy and External Beam Radiation Therapy for Adenocarcinoma of the Prostate. Int J Radiat Oncol Biol Phys. 2021 Jul 01; 110(3):700-707. Hsu IC, Rodgers JP, Shinohara K, Purdy J, Michalski J, Roach M, Vigneault E, Ivker RA, Pryzant RM, Kuettel M, Taussky D, Gustafson GS, Raben A, Sandler HM. PMID: 33186617; PMCID: PMC8107184.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    18. Adjuvant radiation followed by chemotherapy is associated with improved overall survival in endometrial cancer. Gynecol Oncol. 2020 10; 159(1):30-35. Sinha S, Lazar A, Lam A, Anderson EM, Chen LM, Hsu IJ, Yoshida EJ. PMID: 32811681.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    19. PET-detected asymptomatic recurrence is associated with improved survival in recurrent cervical cancer. Abdom Radiol (NY). 2021 01; 46(1):341-350. Peters PN, Pierson WE, Chen LM, Westphalen AC, Chapman JS, Hsu IC. PMID: 32638077.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    20. Simultaneous Metabolic and Perfusion Imaging Using Hyperpolarized 13C MRI Can Evaluate Early and Dose-Dependent Response to Radiation Therapy in a Prostate Cancer Mouse Model. Int J Radiat Oncol Biol Phys. 2020 08 01; 107(5):887-896. Qin H, Zhang V, Bok RA, Santos RD, Cunha JA, Hsu IC, Santos Bs JD, Lee JE, Sukumar S, Larson PEZ, Vigneron DB, Wilson DM, Sriram R, Kurhanewicz J. PMID: 32339646; PMCID: PMC7381368.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    21. Single-fraction brachytherapy as monotherapy for early-stage prostate cancer: The UCSF experience. Brachytherapy. 2019 Jul - Aug; 18(4):470-476. Xu MJ, Chen KS, Chang AJ, Lazar A, Shinohara K, Cunha JAM, Hsu IC. PMID: 30954399.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    22. Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS). Brachytherapy. 2019 Mar - Apr; 18(2):123-132. Holschneider CH, Petereit DG, Chu C, Hsu IC, Ioffe YJ, Klopp AH, Pothuri B, Chen LM, Yashar C. PMID: 30665713.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    23. Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS). Gynecol Oncol. 2019 03; 152(3):540-547. Holschneider CH, Petereit DG, Chu C, Hsu IC, Ioffe YJ, Klopp AH, Pothuri B, Chen LM, Yashar C. PMID: 30665615.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    24. Erratum: "Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers" [Med. Phys. 45 (7), 3449-3459 (2018)]. Med Phys. 2019 Feb; 46(2):1080-1087. Deist TM, Dankers FJWM, Valdes G, Wijsman R, Hsu IC, Oberije C, Lustberg T, van Soest J, Hoebers F, Jochems A, El Naqa I, Wee L, Morin O, Raleigh DR, Bots W, Kaanders JH, Belderbos J, Kwint M, Solberg T, Monshouwer R, Bussink J, Dekker A, Lambin P. PMID: 30730570; PMCID: PMC11078197.
      View in: PubMed   Mentions: 5     Fields:    
    25. Impact of Staging 68Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients With Prostate Cancer. Urology. 2019 03; 125:154-162. Wu SY, Boreta L, Shinohara K, Nguyen H, Gottschalk AR, Hsu IC, Roach M, Westphalen AC, Feng FY, Carroll PR, Chang AJ, Hope TA. PMID: 30580002.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    26. In Reply to Gensheimer and Trister. Int J Radiat Oncol Biol Phys. 2018 12 01; 102(5):1594-1596. Valdes G, Chang AJ, Cunnan A, Solberg TD, Hsu IC, Interian Y, Owen K, Jensen ST, Ungar LH. PMID: 31014789.
      View in: PubMed   Mentions:    Fields:    
    27. Patterns of Recurrence in Node-Positive Cervical Cancer Patients Treated With Contemporary Chemoradiation and Dose Escalation: A Multi-Institutional Study. Pract Radiat Oncol. 2019 Mar; 9(2):e180-e186. Sethi R, Mayadev J, Sethi S, Rash D, Chen LM, Brooks R, Ueda S, Hsu IC. PMID: 30342181.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    28. Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. Lancet Oncol. 2018 11; 19(11):1504-1515. Roach M, Moughan J, Lawton CAF, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR, Shipley WU, Sandler HM. PMID: 30316827; PMCID: PMC6540797.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansCTClinical Trials
    29. The American Brachytherapy Society and the American Radium Society Appropriate Use Criteria Genitourinary Committee Endorse the American Society of Clinical Oncology/Cancer Care Ontario Guidelines. J Clin Oncol. 2018 Sep 13; JCO1800626. Chang AJ, McBride S, Keyes M, Chung HT, Davis BJ, Cox BW, Crook J, Demanes DJ, Hsu IC, Kamrava M, Krauss DJ, Morton G, Orio Iii PF, Roach Iii M, Venkat PS, Vigneault E, Zelefsky MJ. PMID: 30212298.
      View in: PubMed   Mentions:    Fields:    
    30. Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy. J Contemp Brachytherapy. 2018 Jun; 10(3):193-201. Chapman CH, Braunstein SE, Pouliot J, Noworolski SM, Weinberg V, Cunha A, Kurhanewicz J, Gottschalk AR, Roach MI, Hsu IC. PMID: 30038638; PMCID: PMC6052382.
      View in: PubMed   Mentions: 7  
    31. Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers. Med Phys. 2018 Jul; 45(7):3449-3459. Deist TM, Dankers FJWM, Valdes G, Wijsman R, Hsu IC, Oberije C, Lustberg T, van Soest J, Hoebers F, Jochems A, El Naqa I, Wee L, Morin O, Raleigh DR, Bots W, Kaanders JH, Belderbos J, Kwint M, Solberg T, Monshouwer R, Bussink J, Dekker A, Lambin P. PMID: 29763967; PMCID: PMC6095141.
      View in: PubMed   Mentions: 121     Fields:    Translation:Humans
    32. Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities. Adv Radiat Oncol. 2018 Jul-Sep; 3(3):405-411. Xiao C, Moughan J, Movsas B, Konski AA, Hanks GE, Cox JD, Roach M, Zeitzer KL, Lawton CA, Peters CA, Rosenthal SA, Hsu IJ, Horwitz EM, Mishra MV, Michalski JM, Parliament MB, D'Souza DP, Pugh SL, Bruner DW. PMID: 30202809; PMCID: PMC6128023.
      View in: PubMed   Mentions: 2  
    33. Underutilization of brachytherapy and disparities in survival for patients with cervical cancer in California. Gynecol Oncol. 2018 07; 150(1):73-78. Mayadev J, Klapheke A, Yashar C, Hsu IC, Kamrava M, Mundt AJ, Mell LK, Einck J, Benedict S, Valicenti R, Cress R. PMID: 29709291.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    34. Salvage HDR Brachytherapy: Multiple Hypothesis Testing Versus Machine Learning Analysis. Int J Radiat Oncol Biol Phys. 2018 07 01; 101(3):694-703. Valdes G, Chang AJ, Interian Y, Owen K, Jensen ST, Ungar LH, Cunha A, Solberg TD, Hsu IC. PMID: 29709315.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    35. A novel urethral sparing technique for high-dose-rate prostate brachytherapy after transurethral resection of the prostate. Brachytherapy. 2017 Nov - Dec; 16(6):1113-1118. Kunogi H, Cunha JAM, Chang AJ, Gadzinski AJ, Shinohara K, Hsu IC. PMID: 28869143.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    36. Salvage high-dose-rate brachytherapy and external beam radiotherapy for isolated vaginal recurrences of endometrial cancer with no prior adjuvant therapy. Brachytherapy. 2017 Nov - Dec; 16(6):1152-1158. Chapman CH, Maghsoudi K, Littell RD, Chen LM, Hsu IC. PMID: 28802913.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    37. Real-time electromagnetic tracking-based treatment platform for high-dose-rate prostate brachytherapy: Clinical workflows and end-to-end validation. Brachytherapy. 2018 Jan - Feb; 17(1):103-110. Beaulieu L, Racine E, Han DY, Vigneault E, Hsu IC, Cunha JAM. PMID: 28576644.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    38. Radiation Therapy for Recurrent Clear-Cell Cancer of the Ovary. Int J Gynecol Cancer. 2016 11; 26(9):1608-1614. Westhoff GL, Fuh KC, Longacre TA, McNally JL, Hsu IC, Kapp DS, Teng N, Chen LM. PMID: 27575628.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    39. Receiver operating curves and dose-volume analysis of late toxicity with stereotactic body radiation therapy for prostate cancer. Pract Radiat Oncol. 2017 Mar - Apr; 7(2):e109-e116. Zhang L, Johnson J, Gottschalk AR, Chang AJ, Hsu IC, Roach M, Seymour ZA. PMID: 28274401.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    40. Clinical applications of custom-made vaginal cylinders constructed using three-dimensional printing technology. J Contemp Brachytherapy. 2016 Jun; 8(3):208-14. Sethi R, Cunha A, Mellis K, Siauw T, Diederich C, Pouliot J, Hsu IC. PMID: 27504130; PMCID: PMC4965501.
      View in: PubMed   Mentions: 26  
    41. Long-term Outcomes Following Radiation Therapy For Prostate Cancer Patients With Lymph Node Metastases at Diagnosis Treated With and Without Surgery. Am J Clin Oncol. 2016 Apr; 39(2):167-72. Crehange G, Izaguirre A, Weinberg V, Hsu CC, Gottschalk AR, Hsu IC, Shinohara K, Carroll P, Roach M. PMID: 24441584.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    42. Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer. Radiat Oncol. 2016 Jan 21; 11:8. Anwar M, Weinberg V, Seymour Z, Hsu IJ, Roach M, Gottschalk AR. PMID: 26792201; PMCID: PMC4721063.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    43. A method for restricting intracatheter dwell time variance in high-dose-rate brachytherapy plan optimization. Brachytherapy. 2016 Mar-Apr; 15(2):246-51. Cunha A, Siauw T, Hsu IC, Pouliot J. PMID: 26727333.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    44. Sentinel lymph node imaging guided IMRT for prostate cancer: Individualized pelvic radiation therapy versus RTOG guidelines. Adv Radiat Oncol. 2016 Jan-Mar; 1(1):51-58. Chen CP, Johnson J, Seo Y, Weinberg VK, Shinohara K, Hsu IJ, Roach M. PMID: 28799574; PMCID: PMC5506713.
      View in: PubMed   Mentions:
    45. Patient- and treatment-specific predictors of genitourinary function after high-dose-rate monotherapy for favorable prostate cancer. Brachytherapy. 2015 Nov-Dec; 14(6):795-800. Raleigh DR, Chang AJ, Tomlin B, Cunha JA, Braunstein SE, Shinohara K, Gottschalk AR, Roach M, Hsu IC. PMID: 26198421.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    46. Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes. Int J Radiat Oncol Biol Phys. 2015 Aug 01; 92(5):1093-1100. Tinkle CL, Weinberg V, Chen LM, Littell R, Cunha JAM, Sethi RA, Chan JK, Hsu IC. PMID: 26194683.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    47. Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter? BJU Int. 2015 Nov; 116(5):713-20. Hsu CC, Paciorek AT, Cooperberg MR, Roach M, Hsu IC, Carroll PR. PMID: 25600860.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    48. Dose-volume analysis and the temporal nature of toxicity with stereotactic body radiation therapy for prostate cancer. Pract Radiat Oncol. 2015 Sep-Oct; 5(5):e465-e472. Seymour ZA, Chang AJ, Zhang L, Kirby N, Descovich M, Roach M, Hsu IC, Gottschalk AR. PMID: 25795252.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    49. Evaluation of PC-ISO for customized, 3D Printed, gynecologic 192-Ir HDR brachytherapy applicators. J Appl Clin Med Phys. 2015 Jan 08; 16(1):5168. Cunha JA, Mellis K, Sethi R, Siauw T, Sudhyadhom A, Garg A, Goldberg K, Hsu IC, Pouliot J. PMID: 25679174; PMCID: PMC5689973.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    50. Bladder wall recurrence of prostate cancer after high-dose-rate brachytherapy. Brachytherapy. 2015 Mar-Apr; 14(2):185-8. Raleigh DR, Hsu IC, Braunstein S, Chang AJ, Simko JP, Roach M. PMID: 25533416.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    51. ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancer. Oncology (Williston Park). 2014 Dec; 28(12):1125-30, 1132-6. Gustafson GS, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Hsu IC, Lloyd S, Mclaughlin PW, Merrick GS, Showalter TN, Taira AV, Vapiwala N, Yamada Y, Davis BJ. PMID: 25510812.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    52. Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer. Int J Hyperthermia. 2014 Aug; 30(5):285-94. Zagar TM, Vujaskovic Z, Formenti S, Rugo H, Muggia F, O'Connor B, Myerson R, Stauffer P, Hsu IC, Diederich C, Straube W, Boss MK, Boico A, Craciunescu O, Maccarini P, Needham D, Borys N, Blackwell KL, Dewhirst MW. PMID: 25144817; PMCID: PMC4162656.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    53. Pre-plan parameters predict post-implant D90 ≥ 140 Gy for (125)I permanent prostate implants. J Contemp Brachytherapy. 2014 Jun; 6(2):143-53. Alexander J, Weinberg V, Gottschalk AR, Hsu IC, Shinohara K, Roach M. PMID: 25097554; PMCID: PMC4105644.
      View in: PubMed   Mentions: 2  
    54. ACR Appropriateness Criteria® Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer. Am J Clin Oncol. 2014 Jun; 37(3):278-88. Nguyen PL, Aizer A, Assimos DG, D'Amico AV, Frank SJ, Gottschalk AR, Gustafson GS, Hsu IC, McLaughlin PW, Merrick G, Rosenthal SA, Showalter TN, Taira AV, Vapiwala N, Yamada Y, Davis BJ, American College of Radiology, Expert Panel on Radiation OncologyProstate. PMID: 25180754.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    55. Response to Drs Rogers, Hayes, and Demanes. Brachytherapy. 2014 Sep-Oct; 13(5):523-5. Hsu IC, Yamada Y, Assimos DG, D'Amico AV, Davis BJ, Frank SJ, Gottschalk AR, Gustafson GS, McLaughlin PW, Nguyen PL, Rosenthal SA, Taira AV, Vapiwala N, Merrick G, Expert Panel on Radiation Oncology–Prostate. PMID: 24880587.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    56. Quality improvement of International Classification of Diseases, 9th revision, diagnosis coding in radiation oncology: single-institution prospective study at University of California, San Francisco. Pract Radiat Oncol. 2015 Jan-Feb; 5(1):e45-51. Chen CP, Braunstein S, Mourad M, Hsu IC, Haas-Kogan D, Roach M, Fogh SE. PMID: 25413428.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    57. Model-based feasibility assessment and evaluation of prostate hyperthermia with a commercial MR-guided endorectal HIFU ablation array. Med Phys. 2014 Mar; 41(3):033301. Salgaonkar VA, Prakash P, Rieke V, Ozhinsky E, Plata J, Kurhanewicz J, Hsu IC, Diederich CJ. PMID: 24593742; PMCID: PMC3987720.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    58. A training phantom for ultrasound-guided needle insertion and suturing. Brachytherapy. 2014 Jul-Aug; 13(4):413-9. Nattagh K, Siauw T, Pouliot J, Hsu IC, Cunha JA. PMID: 24529964.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    59. A review of safety, quality management, and practice guidelines for high-dose-rate brachytherapy: executive summary. Pract Radiat Oncol. 2014 Mar-Apr; 4(2):65-70. Thomadsen BR, Erickson BA, Eifel PJ, Hsu IC, Patel RR, Petereit DG, Fraass BA, Rivard MJ. PMID: 24890345.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    60. Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir. Radiat Oncol. 2014 Feb 02; 9:42. Anwar M, Weinberg V, Chang AJ, Hsu IC, Roach M, Gottschalk A. PMID: 24484652; PMCID: PMC3923240.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    61. Dosimetric Analysis of Radiation Therapy Oncology Group 0321: The Importance of Urethral Dose. Practical Radiation Oncology. 2014; 4:27-34. Hsu IC, Hunt D, Straube, W, Pouliot J, Cunha A, Krishnamurthy D, Sandler H.
    62. ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer. Brachytherapy. 2014 Jan-Feb; 13(1):27-31. Hsu IC, Yamada Y, Assimos DG, D'Amico AV, Davis BJ, Frank SJ, Gottschalk AR, Gustafson GS, McLaughlin PW, Nguyen PL, Rosenthal SA, Taira AV, Vapiwala N, Merrick G. PMID: 24368283.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    63. Components of a hyperthermia clinic: recommendations for staffing, equipment, and treatment monitoring. Int J Hyperthermia. 2014 Feb; 30(1):1-5. Myerson RJ, Moros EG, Diederich CJ, Haemmerich D, Hurwitz MD, Hsu IC, McGough RJ, Nau WH, Straube WL, Turner PF, Vujaskovic Z, Stauffer PR. PMID: 24350642.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    64. Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: implications for focal salvage brachytherapy. Radiother Oncol. 2013 Nov; 109(2):246-50. Crehange G, Krishnamurthy D, Cunha JA, Pickett B, Kurhanewicz J, Hsu IC, Gottschalk AR, Shinohara K, Roach M, Pouliot J. PMID: 24231238; PMCID: PMC4081029.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    65. Model-based feasibility assessment and evaluation of prostate hyperthermia with a commercial MRI-guided endorectal high intensity focused ultrasound ablation array. J Acoust Soc Am. 2013 Nov; 134(5):4180. Salgaonkar VA, Rieke V, Ozhinsky E, Prakash P, Plata J, Kurhanewicz J, Hsu IC, Diederich CJ. PMID: 24181657.
      View in: PubMed   Mentions:
    66. A dosimetric evaluation of using a single treatment plan for multiple treatment fractions within a given applicator insertion in gynecologic brachytherapy. Brachytherapy. 2013 Sep-Oct; 12(5):487-94. Pinnaduwage DS, Cunha JA, Weinberg V, Krishnamurthy D, Nash M, Hsu IC, Pouliot J. PMID: 23582467.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    67. Dosimetric analysis of radiation therapy oncology group 0321: the importance of urethral dose. Pract Radiat Oncol. 2014 Jan-Feb; 4(1):27-34. Hsu IC, Hunt D, Straube W, Pouliot J, Cunha A, Krishnamurthy D, Sandler H. PMID: 24621420; PMCID: PMC4000550.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    68. Prostate-specific antigen response after short-term hormone therapy plus external-beam radiotherapy and outcome in patients treated on Radiation Therapy Oncology Group study 9413. Cancer. 2013 Jun 01; 119(11):1999-2004. Cury FL, Hunt D, Roach M, Shipley W, Gore E, Hsu IC, Krisch RE, Seider MJ, Sandler H, Lawton C. PMID: 23504930; PMCID: PMC3663874.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    69. Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes. Int J Radiat Oncol Biol Phys. 2013 Jun 01; 86(2):324-9. Chen CP, Weinberg V, Shinohara K, Roach M, Nash M, Gottschalk A, Chang AJ, Hsu IC. PMID: 23474112.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansPHPublic Health
    70. Computer-assisted, atlas-based segmentation for target volume delineation in whole pelvic IMRT for prostate cancer. Technol Cancer Res Treat. 2013 Jun; 12(3):199-206. Pejavar S, Yom SS, Hwang A, Speight J, Gottschalk A, Hsu IC, Roach M, Xia P. PMID: 23289478.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    71. NPIP: A skew line needle configuration optimization system for HDR brachytherapy. Med Phys. 2012 Jul; 39(7):4339-46. Siauw T, Cunha A, Berenson D, Atamturk A, Hsu IC, Goldberg K, Pouliot J. PMID: 22830767.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    72. Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):370-7. Hsu CC, Hsu H, Pickett B, Crehange G, Hsu IC, Dea R, Weinberg V, Gottschalk AR, Kurhanewicz J, Shinohara K, Roach M. PMID: 22672747.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansPHPublic Health
    73. ACR Appropriateness Criteria® external-beam radiation therapy treatment planning for clinically localized prostate cancer. J Am Coll Radiol. 2012 Apr; 9(4):233-8. Abdel-Wahab M, Mahmoud O, Merrick G, Hsu IC, Arterbery VE, Ciezki JP, Frank SJ, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamada Y. PMID: 22469373.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    74. American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy. Brachytherapy. 2012 Jan-Feb; 11(1):20-32. Yamada Y, Rogers L, Demanes DJ, Morton G, Prestidge BR, Pouliot J, Cohen GN, Zaider M, Ghilezan M, Hsu IC, American Brachytherapy Society. PMID: 22265435.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    75. ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancer. Am J Clin Oncol. 2011 Dec; 34(6):636-47. Moran BJ, DeRose P, Hsu IC, Abdel-Wahab M, Arterbery VE, Ciezki JP, Frank SJ, Mohler JL, Rosenthal SA, Rossi CJ, Yamada Y, Merrick GS. PMID: 22101389.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    76. Temporal compartmental dosing effects for robotic prostate stereotactic body radiotherapy. Phys Med Biol. 2011 Dec 21; 56(24):7767-75. Shiao SL, Sahgal A, Hu W, Jabbari S, Chuang C, Descovich M, Hsu IC, Gottschalk AR, Roach M, Ma L. PMID: 22107791.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    77. Urethra low-dose tunnels: validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for prostate high-dose-rate brachytherapy. Brachytherapy. 2012 Sep-Oct; 11(5):348-53. Cunha JA, Pouliot J, Weinberg V, Wang-Chesebro A, Roach M, Hsu IC. PMID: 21937284.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    78. American College of Radiology Appropriateness Criteria(®)--locally advanced (high-risk) prostate cancer. Clin Oncol (R Coll Radiol). 2012 Feb; 24(1):43-51. Ciezki JP, Hsu IC, Abdel-Wahab M, Arterbery VE, Frank SJ, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamada Y, Merrick G, American College of Radiology Appropriateness Criteria. PMID: 21875782.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    79. IPIP: A new approach to inverse planning for HDR brachytherapy by directly optimizing dosimetric indices. Med Phys. 2011 Jul; 38(7):4045-51. Siauw T, Cunha A, Atamtürk A, Hsu IC, Pouliot J, Goldberg K. PMID: 21859003.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    80. Implant strategies for endocervical and interstitial ultrasound hyperthermia adjunct to HDR brachytherapy for the treatment of cervical cancer. Phys Med Biol. 2011 Jul 07; 56(13):3967-84. Wootton JH, Prakash P, Hsu IC, Diederich CJ. PMID: 21666290.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    81. American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer. Brachytherapy. 2011 Sep-Oct; 10(5):357-62. Expert Panel on Radiation Oncology-Prostate, Frank SJ, Arterbery VE, Hsu IC, Abdel-Wahab M, Ciezki JP, Hahn NM, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamada Y, Merrick G. PMID: 21497562.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    82. Interactive, multi-modality image registrations for combined MRI/MRSI-planned HDR prostate brachytherapy. J Contemp Brachytherapy. 2011 Mar 31; 3(1):26-31. Reed G, Cunha JA, Noworolski S, Kurhanewicz J, Vigneron D, Hsu IC, Pouliot J. PMID: 23606866; PMCID: PMC3627724.
      View in: PubMed   Mentions: 4  
    83. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources. Brachytherapy. 2011 Nov-Dec; 10(6):461-5. Krishnamurthy D, Weinberg V, Cunha JA, Hsu IC, Pouliot J. PMID: 21397569.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    84. Endocervical ultrasound applicator for integrated hyperthermia and HDR brachytherapy in the treatment of locally advanced cervical carcinoma. Med Phys. 2011 Feb; 38(2):598-611. Wootton JH, Hsu IC, Diederich CJ. PMID: 21452697; PMCID: PMC3033875.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    85. Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):228-34. Jabbari S, Weinberg VK, Kaprealian T, Hsu IC, Ma L, Chuang C, Descovich M, Shiao S, Shinohara K, Roach M, Gottschalk AR. PMID: 21183287.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    86. High-dose-rate brachytherapy boost for prostate cancer: comparison of two different fractionation schemes. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):222-7. Kaprealian T, Weinberg V, Speight JL, Gottschalk AR, Roach M, Shinohara K, Hsu IC. PMID: 21163586.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    87. American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 2011 Mar 01; 79(3):641-9. Erickson BA, Demanes DJ, Ibbott GS, Hayes JK, Hsu IC, Morris DE, Rabinovitch RA, Tward JD, Rosenthal SA. PMID: 21106308.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    88. Toward adaptive stereotactic robotic brachytherapy for prostate cancer: demonstration of an adaptive workflow incorporating inverse planning and an MR stealth robot. Minim Invasive Ther Allied Technol. 2010 Aug; 19(4):189-202. Cunha JA, Hsu IC, Pouliot J, Roach Iii M, Shinohara K, Kurhanewicz J, Reed G, Stoianovici D. PMID: 20642386; PMCID: PMC3108452.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    89. Dosimetric impact of interfraction catheter movement in high-dose rate prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2011 May 01; 80(1):85-90. Foster W, Cunha JA, Hsu IC, Weinberg V, Krishnamurthy D, Pouliot J. PMID: 20605353.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    90. Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321. Int J Radiat Oncol Biol Phys. 2010 Nov 01; 78(3):751-8. Hsu IC, Bae K, Shinohara K, Pouliot J, Purdy J, Ibbott G, Speight J, Vigneault E, Ivker R, Sandler H. PMID: 20207506; PMCID: PMC2946454.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCTClinical Trials
    91. Investigation of geometric distortions on magnetic resonance and cone beam computed tomography images used for planning and verification of high-dose rate brachytherapy cervical cancer treatment. Brachytherapy. 2010 Jul-Sep; 9(3):266-73. Aubry JF, Cheung J, Morin O, Beaulieu L, Hsu IC, Pouliot J. PMID: 20149759.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    92. Optimisation-based thermal treatment planning for catheter-based ultrasound hyperthermia. Int J Hyperthermia. 2010 Feb; 26(1):39-55. Chen X, Diederich CJ, Wootton JH, Pouliot J, Hsu IC. PMID: 20100052.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    93. Equivalent biochemical control and improved prostate-specific antigen nadir after permanent prostate seed implant brachytherapy versus high-dose three-dimensional conformal radiotherapy and high-dose conformal proton beam radiotherapy boost. Int J Radiat Oncol Biol Phys. 2010 Jan 01; 76(1):36-42. Jabbari S, Weinberg VK, Shinohara K, Speight JL, Gottschalk AR, Hsu IC, Pickett B, McLaughlin PW, Sandler HM, Roach M. PMID: 19409729.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    94. Adjuvant radiation therapy in stage III node-positive uterine cancer. Gynecol Oncol. 2009 Nov; 115(2):239-43. Schmid S, Hsu IC, Hu JM, Sherman AE, Osann K, Kapp DS, Chan JK. PMID: 19679341.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    95. High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience. Brachytherapy. 2009 Oct-Dec; 8(4):339-44. Jabbari S, Hsu IC, Kawakami J, Weinberg VK, Speight JL, Gottschalk AR, Roach M, Shinohara K. PMID: 19428310.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    96. High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up. Int J Radiat Oncol Biol Phys. 2009 Dec 01; 75(5):1329-34. Kim DH, Wang-Chesebro A, Weinberg V, Pouliot J, Chen LM, Speight J, Littell R, Hsu IC. PMID: 19409728.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    97. T2-Weighted endorectal magnetic resonance imaging of prostate cancer after external beam radiation therapy. Int Braz J Urol. 2009 Mar-Apr; 35(2):171-80; discussion 181-2. Westphalen AC, Kurhanewicz J, Cunha RM, Hsu IC, Kornak J, Zhao S, Coakley FV. PMID: 19409121; PMCID: PMC4532331.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    98. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy. BJU Int. 2009 Sep; 104(5):600-4. Aaronson DS, Yamasaki I, Gottschalk A, Speight J, Hsu IC, Pickett B, Roach M, Shinohara K. PMID: 19245439.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    99. Planning Fireworks Trajectories for Steerable Medical Needles to Reduce Patient Trauma. Rep U S. 2009; 4517-4522. Xu J, Duindam V, Alterovitz R, Pouliot J, Cunha JA, Hsu IC, Goldberg K. PMID: 25946259; PMCID: PMC4403730.
      View in: PubMed   Mentions: 4  
    100. Dosimetric equivalence of nonstandard HDR brachytherapy catheter patterns. Med Phys. 2009 Jan; 36(1):233-9. Cunha JA, Hsu IC, Pouliot J. PMID: 19235391.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    101. Sensorless motion planning for medical needle insertion in deformable tissues. IEEE Trans Inf Technol Biomed. 2009 Mar; 13(2):217-25. Alterovitz R, Goldberg KY, Pouliot J, Hsu IC. PMID: 19126473; PMCID: PMC2822650.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    102. Comparison of dosimetric and biologic effective dose parameters for prostate and urethra using 131 Cs and 125 I for prostate permanent implant brachytherapy. Int J Radiat Oncol Biol Phys. 2008 Sep 01; 72(1):247-54. Sahgal A, Jabbari S, Chen J, Pickett B, Roach M, Weinberg V, Hsu IC, Pouliot J. PMID: 18722275.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    103. Pretreatment endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2009 Mar 01; 73(3):665-71. Joseph T, McKenna DA, Westphalen AC, Coakley FV, Zhao S, Lu Y, Hsu IC, Roach M, Kurhanewicz J. PMID: 18760545; PMCID: PMC2737354.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    104. Inverse planning simulated annealing for magnetic resonance imaging-based intracavitary high-dose-rate brachytherapy for cervical cancer. Brachytherapy. 2008 Jul-Sep; 7(3):242-7. Kubicky CD, Yeh BM, Lessard E, Joe BN, Speight JL, Pouliot J, Hsu IC. PMID: 18468959.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    105. Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008 Sep 01; 72(1):69-77. Chan LW, Xia P, Gottschalk AR, Akazawa M, Scala M, Pickett B, Hsu IC, Speight J, Roach M. PMID: 18342454.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    106. Class solution in inverse planned HDR prostate brachytherapy for dose escalation of DIL defined by combined MRI/MRSI. Radiother Oncol. 2008 Jul; 88(1):148-55. Kim Y, Hsu IC, Lessard E, Kurhanewicz J, Noworolski SM, Pouliot J. PMID: 18083260; PMCID: PMC4523126.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    107. Measurement of craniocaudal catheter displacement between fractions in computed tomography-based high dose rate brachytherapy of prostate cancer. J Appl Clin Med Phys. 2007 Sep 17; 8(4):1-13. Kim Y, Hsu IJ, Pouliot J. PMID: 18449148; PMCID: PMC5722614.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    108. Daily electronic portal imaging of implanted gold seed fiducials in patients undergoing radiotherapy after radical prostatectomy. Int J Radiat Oncol Biol Phys. 2007 Feb 01; 67(2):610-9. Schiffner DC, Gottschalk AR, Lometti M, Aubin M, Pouliot J, Speight J, Hsu IC, Shinohara K, Roach M. PMID: 17236978.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    109. Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys. 2007 Mar 15; 67(4):1106-12. Lee B, Shinohara K, Weinberg V, Gottschalk AR, Pouliot J, Roach M, Hsu IC. PMID: 17197119.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    110. Optimization of HDR brachytherapy dose distributions using linear programming with penalty costs. Med Phys. 2006 Nov; 33(11):4012-9. Alterovitz R, Lessard E, Pouliot J, Hsu IC, O'Brien JF, Goldberg K. PMID: 17153381.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    111. Registration of MR prostate images with biomechanical modeling and nonlinear parameter estimation. Med Phys. 2006 Feb; 33(2):446-54. Alterovitz R, Goldberg K, Pouliot J, Hsu IC, Kim Y, Noworolski SM, Kurhanewicz J. PMID: 16532952.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    112. Expandable and rigid endorectal coils for prostate MRI: impact on prostate distortion and rigid image registration. Med Phys. 2005 Dec; 32(12):3569-78. Kim Y, Hsu IC, Pouliot J, Noworolski SM, Vigneron DB, Kurhanewicz J. PMID: 16475755.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    113. 3D inverse treatment planning for the tandem and ovoid applicator in cervical cancer. Int J Radiat Oncol Biol Phys. 2005 Nov 15; 63(4):1270-4. Dewitt KD, Hsu IC, Speight J, Weinberg VK, Lessard E, Pouliot J. PMID: 16253782.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    114. Optimization of dose distribution for HDR brachytherapy of the prostate using Attraction-Repulsion Model. Int J Radiat Oncol Biol Phys. 2006 Feb 01; 64(2):643-9. Sumida I, Shiomi H, Yoshioka Y, Inoue T, Lessard E, Hsu IC, Pouliot J. PMID: 16289907.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    115. Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer. Brachytherapy. 2005; 4(3):202-6. Hsu IC, Cabrera AR, Weinberg V, Speight J, Gottschalk AR, Roach M, Shinohara K. PMID: 16182220.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    116. Dose uncertainty due to computed tomography (CT) slice thickness in CT-based high dose rate brachytherapy of the prostate cancer. Med Phys. 2004 Sep; 31(9):2543-8. Kim Y, Hsu IC, Lessard E, Pouliot J, Vujic J. PMID: 15487736.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    117. Radiation dosimetry of a conformal heat-brachytherapy applicator. Technol Cancer Res Treat. 2004 Aug; 3(4):347-58. Taschereau R, Stauffer PR, Hsu IC, Schlorff JL, Milligan AJ, Pouliot J. PMID: 15270585.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    118. Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys. 2004 Jul 15; 59(4):1196-207. Pouliot J, Kim Y, Lessard E, Hsu IC, Vigneron DB, Kurhanewicz J. PMID: 15234056.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansPHPublic Health
    119. Dosimetric impact of prostate volume change between CT-based HDR brachytherapy fractions. Int J Radiat Oncol Biol Phys. 2004 Jul 15; 59(4):1208-16. Kim Y, Hsu IC, Lessard E, Vujic J, Pouliot J. PMID: 15234057.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    120. Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapy. Brachytherapy. 2004; 3(3):147-52. Hsu IC, Lessard E, Weinberg V, Pouliot J. PMID: 15533807.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    121. Image registration for prostate MR spectroscopy using modeling and optimization of force and stiffness parameters. Conf Proc IEEE Eng Med Biol Soc. 2004; 2004:1722-5. Alterovitz R, Goldberg K, Kurhanewicz J, Pouliot J, Hsu IC. PMID: 17272037.
      View in: PubMed   Mentions: 1     Fields:    
    122. Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. Int J Radiat Oncol Biol Phys. 2003 Nov 01; 57(3):635-44. Langen KM, Pouliot J, Anezinos C, Aubin M, Gottschalk AR, Hsu IC, Lowther D, Liu YM, Shinohara K, Verhey LJ, Weinberg V, Roach M. PMID: 14529767.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    123. Analysis of interaction between number of implant catheters and dose-volume histograms in prostate high- dose-rate brachytherapy using a computer model. Int J Radiat Oncol Biol Phys. 2003 Jun 01; 56(2):586-91. Charra-Brunaud C, Hsu IC, Weinberg V, Pouliot J. PMID: 12738336.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    124. Simulating needle insertion and radioactive seed implantation for prostate brachytherapy. Stud Health Technol Inform. 2003; 94:19-25. Alterovitz R, Pouliot J, Taschereau R, Hsu IC, Goldberg K. PMID: 15455857.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    125. Inverse planning for interstitial gynecologic template brachytherapy: truly anatomy-based planning. Int J Radiat Oncol Biol Phys. 2002 Nov 15; 54(4):1243-51. Lessard E, Hsu IC, Pouliot J. PMID: 12419454.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    126. Early clinical experience with anatomy-based inverse planning dose optimization for high-dose-rate boost of the prostate. Int J Radiat Oncol Biol Phys. 2002 Sep 01; 54(1):86-100. Lachance B, Béliveau-Nadeau D, Lessard E, Chrétien M, Hsu IC, Pouliot J, Beaulieu L, Vigneault E. PMID: 12182978.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    127. A comparison between tandem and ovoids and interstitial gynecologic template brachytherapy dosimetry using a hypothetical computer model. Int J Radiat Oncol Biol Phys. 2002 Feb 01; 52(2):538-43. Hsu IC, Speight J, Hai J, Vigneault E, Phillips T, Pouliot J. PMID: 11872302.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    128. Managing nasopharyngeal carcinoma with intracavitary brachytherapy: one institution's 45-year experience. Brachytherapy. 2002; 1(2):74-82. Lee N, Hoffman R, Phillips TL, Xia P, Quivey JM, Weinberg V, Hsu IC. PMID: 15062174.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    129. Prostate volume change after radioactive seed implantation: possible benefit of improved dose volume histogram with perioperative steroid. Int J Radiat Oncol Biol Phys. 2000 Dec 01; 48(5):1461-7. Speight JL, Shinohara K, Pickett B, Weinberg VK, Hsu IC, Roach M. PMID: 11121649.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    130. Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation. Int J Radiat Oncol Biol Phys. 2000 Mar 01; 46(4):851-8. Hsu IC, Pickett B, Shinohara K, Krieg R, Roach M, Phillips T. PMID: 10705005.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    131. Re-examining the role of prostate-specific antigen density in predicting outcome for clinically localized prostate cancer. Urology. 1997 Jul; 50(1):73-8. Ingenito AC, Ennis RD, Hsu IC, Begg MD, Benson MC, Schiff PB. PMID: 9218022.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    I-Chow's Networks
    Concepts (283)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (72)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-5-g94c7c43e on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.